{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T04:12:39Z","timestamp":1778127159899,"version":"3.51.4"},"reference-count":49,"publisher":"The Endocrine Society","issue":"12","license":[{"start":{"date-parts":[[2021,11,8]],"date-time":"2021-11-08T00:00:00Z","timestamp":1636329600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,12,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Ovarian hyperthecosis (OHT), severe hyperandrogenism after menopause in the absence of ovarian or adrenal tumors, is usually treated by surgical excision. We report a 58-year-old woman presenting with severe hyperandrogenism (serum testosterone 15.7-31.0 nmol\/L, normal female &amp;lt;1.8 nmol\/L) with menopausal gonadotropins and virilization but no adrenal or ovarian lesions. Multisteroid profiling by liquid chromatography mass spectrometry (LCMS) of adrenal and ovarian vein samples identified strong gradients in the left ovarian vein (10- to 30-fold vs peripheral blood in 17OHP4, 17 hydroxyprogesterone, 17 hydroxypregnenolone, androstenedione, testosterone, dehydroepiandrosterone) but the right ovarian vein could not be cannulated with the same findings in a second ovarian vein cannulation. OHT diagnosis was confirmed by an injection of a depot pure gonadotropin-releasing hormone (GnRH) antagonist (80 mg Degarelix, Ferring) producing a rapid (&amp;lt;24 hour) and complete suppression of ovarian steroidogenesis as well as serum luteinizing hormone and follicle-stimulating hormone lasting at least 8 weeks, with reduction in virilization but injection site reaction and flushing and vaginal spotting ameliorated by an estradiol patch. Serum testosterone remained suppressed at 313 days after the first dose despite recovery of menopausal gonadotropins by day 278 days. This illustrates use of multisteroid LCMS profiling for confirmation of the OHT diagnosis by ovarian and adrenal vein sampling and monitoring of treatment by peripheral blood sampling. Injection of a depot pure GnRH antagonist produced rapid and long-term complete suppression of ovarian steroidogenesis maintained over 10 months. Hence a depot pure GnRH antagonist can not only rapidly confirm the OHT diagnosis but also induce long-term remission of severe hyperandrogenism without surgery.<\/jats:p>","DOI":"10.1210\/jendso\/bvab167","type":"journal-article","created":{"date-parts":[[2021,11,8]],"date-time":"2021-11-08T19:00:05Z","timestamp":1636398005000},"source":"Crossref","is-referenced-by-count":5,"title":["Depot Pure GnRH Antagonist for Long-term Treatment of Ovarian Hyperthecosis Monitored by Multisteroid LCMS Profiling"],"prefix":"10.1210","volume":"5","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7109-9680","authenticated-orcid":false,"given":"Huajing","family":"Ni","sequence":"first","affiliation":[{"name":"Department of Andrology, Concord Hospital, Sydney, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3800-6603","authenticated-orcid":false,"given":"Robert","family":"Schmidli","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Canberra Hospital, Canberra, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sasha","family":"Savkovic","sequence":"additional","affiliation":[{"name":"Department of Andrology, Concord Hospital, Sydney, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simone I","family":"Strasser","sequence":"additional","affiliation":[{"name":"AW Morrow Gastroenterology & Liver Centre, Royal Prince Alfred Hospital, Sydney, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julie","family":"Hetherington","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Royal Prince Alfred Hospital, Sydney, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reena","family":"Desai","sequence":"additional","affiliation":[{"name":"ANZAC Research Institute, University of Sydney, Sydney, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4200-7476","authenticated-orcid":false,"given":"David J","family":"Handelsman","sequence":"additional","affiliation":[{"name":"Department of Andrology, Concord Hospital, Sydney, Australia"},{"name":"ANZAC Research Institute, University of Sydney, Sydney, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"80","published-online":{"date-parts":[[2021,11,8]]},"reference":[{"issue":"5","key":"2021120512262127200_CIT0001","doi-asserted-by":"crossref","first-page":"587","DOI":"10.7863\/jum.2009.28.5.587","article-title":"Ovarian stromal hyperthecosis: sonographic features and histologic associations","volume":"28","author":"Brown","year":"2009","journal-title":"J Ultrasound Med."},{"key":"2021120512262127200_CIT0002","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.clinms.2018.12.003","article-title":"Simultaneous measurement of 18 steroids in human and mouse serum by liquid chromatography\u2013mass spectrometry without derivatization to profile the classical and alternate pathways of androgen synthesis and metabolism","volume":"11","author":"Desai","year":"2019","journal-title":"Clin Mass Spectrom."},{"issue":"1","key":"2021120512262127200_CIT0003","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/cen.13492","article-title":"Clinical case seminar: postmenopausal androgen excess-challenges in diagnostic work-up and management of ovarian thecosis","volume":"88","author":"Mamoojee","year":"2018","journal-title":"Clin Endocrinol (Oxf)."},{"issue":"2","key":"2021120512262127200_CIT0004","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1210\/jc.2003-031122","article-title":"Androgen excess in women: experience with over 1000 consecutive patients","volume":"89","author":"Azziz","year":"2004","journal-title":"J Clin Endocrinol Metab."},{"issue":"1","key":"2021120512262127200_CIT0005","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1210\/jc.2005-1457","article-title":"Extensive clinical experience: relative prevalence of different androgen excess disorders in 950 women referred because of clinical hyperandrogenism","volume":"91","author":"Carmina","year":"2006","journal-title":"J Clin Endocrinol Metab."},{"issue":"6","key":"2021120512262127200_CIT0006","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1093\/humupd\/dmy022","article-title":"Understanding variation in prevalence estimates of polycystic ovary syndrome: a systematic review and meta-analysis","volume":"24","author":"Skiba","year":"2018","journal-title":"Hum Reprod Update."},{"issue":"12","key":"2021120512262127200_CIT0007","doi-asserted-by":"crossref","first-page":"2841","DOI":"10.1093\/humrep\/dew218","article-title":"The prevalence and phenotypic features of polycystic ovary syndrome: a systematic review and meta-analysis","volume":"31","author":"Bozdag","year":"2016","journal-title":"Hum Reprod."},{"issue":"2","key":"2021120512262127200_CIT0008","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1093\/humrep\/dep399","article-title":"The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria","volume":"25","author":"March","year":"2010","journal-title":"Hum Reprod."},{"issue":"4","key":"2021120512262127200_CIT0009","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/S0015-0282(99)00641-X","article-title":"Serum testosterone levels decrease in middle age in women with the polycystic ovary syndrome","volume":"73","author":"Winters","year":"2000","journal-title":"Fertil Steril."},{"issue":"3","key":"2021120512262127200_CIT0010","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1210\/jc.2010-0130","article-title":"Hyperandrogenism in women with polycystic ovary syndrome persists after menopause","volume":"96","author":"Markopoulos","year":"2011","journal-title":"J Clin Endocrinol Metab."},{"issue":"5","key":"2021120512262127200_CIT0011","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1210\/er.2018-00020","article-title":"Circulating testosterone as the hormonal basis of sex differences in athletic performance","volume":"39","author":"Handelsman","year":"2018","journal-title":"Endocr Rev."},{"issue":"3","key":"2021120512262127200_CIT0012","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1210\/jc.2017-02426","article-title":"Causes, patterns, and severity of androgen excess in 1205 consecutively recruited women","volume":"103","author":"Elhassan","year":"2018","journal-title":"J Clin Endocrinol Metab."},{"issue":"2","key":"2021120512262127200_CIT0013","doi-asserted-by":"crossref","first-page":"R79","DOI":"10.1530\/EJE-14-0468","article-title":"Hyperandrogenism after menopause","volume":"172","author":"Markopoulos","year":"2015","journal-title":"Eur J Endocrinol."},{"issue":"2","key":"2021120512262127200_CIT0014","doi-asserted-by":"crossref","first-page":"R51","DOI":"10.1530\/EJE-16-0461","article-title":"Management of endocrine disease: imaging for the diagnosis of malignancy in incidentally discovered adrenal masses: a systematic review and meta-analysis","volume":"175","author":"Dinnes","year":"2016","journal-title":"Eur J Endocrinol."},{"issue":"5","key":"2021120512262127200_CIT0015","first-page":"1317","article-title":"Extensive personal experience: adrenocortical tumors","volume":"82","author":"Latronico","year":"1997","journal-title":"J Clin Endocrinol Metab."},{"issue":"7","key":"2021120512262127200_CIT0016","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1590\/S0004-27302008000700016","article-title":"Ovarian hyperthecosis in the context of an adrenal incidentaloma in a postmenopausal woman","volume":"52","author":"Marcondes","year":"2008","journal-title":"Arq Bras Endocrinol Metabol."},{"issue":"6","key":"2021120512262127200_CIT0017","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1016\/S0039-6060(03)00410-0","article-title":"Androgen-secreting adrenal tumors","volume":"134","author":"Cordera","year":"2003","journal-title":"Surgery."},{"issue":"6","key":"2021120512262127200_CIT0018","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1016\/j.surg.2004.06.046","article-title":"Profile and outcome of pure androgen-secreting adrenal tumors in women: experience of 21 cases","volume":"136","author":"Moreno","year":"2004","journal-title":"Surgery."},{"issue":"1","key":"2021120512262127200_CIT0019","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1530\/EJE-17-0111","article-title":"Discriminating between virilizing ovary tumors and ovary hyperthecosis in postmenopausal women: clinical data, hormonal profiles and image studies","volume":"177","author":"Yance","year":"2017","journal-title":"Eur J Endocrinol."},{"issue":"5","key":"2021120512262127200_CIT0020","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1111\/j.1365-2265.1994.tb01820.x","article-title":"Androgen suppressive effect of GnRH agonist in ovarian hyperthecosis and virilizing tumours","volume":"41","author":"Pascale","year":"1994","journal-title":"Clin Endocrinol (Oxf)."},{"issue":"6","key":"2021120512262127200_CIT0021","first-page":"1789","article-title":"Type B insulin resistance masquerading as ovarian hyperthecosis","volume":"102","author":"Brown","year":"2017","journal-title":"J Clin Endocrinol Metab."},{"key":"2021120512262127200_CIT0022","doi-asserted-by":"crossref","first-page":":e232783","DOI":"10.1136\/bcr-2019-232783","article-title":"Severe hyperandrogenism due to ovarian hyperthecosis in a young woman","volume":"12","author":"Goyal","year":"2019","journal-title":"BMJ Case Rep"},{"issue":"2","key":"2021120512262127200_CIT0023","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1210\/jcem-33-2-199","article-title":"Combined ovarian and adrenal vein catheterization to determine the site(s) of androgen overproduction in hirsute women","volume":"33","author":"Kirschner","year":"1971","journal-title":"J Clin Endocrinol Metab."},{"issue":"2","key":"2021120512262127200_CIT0024","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/BF02577904","article-title":"Technical difficulties of selective venous blood sampling in the differential diagnosis of female hyperandrogenism","volume":"9","author":"S\u00f6rensen","year":"1986","journal-title":"Cardiovasc Intervent Radiol."},{"issue":"1","key":"2021120512262127200_CIT0025","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1046\/j.1365-2265.2003.01792.x","article-title":"Is ovarian and adrenal venous catheterization and sampling helpful in the investigation of hyperandrogenic women?","volume":"59","author":"Kaltsas","year":"2003","journal-title":"Clin Endocrinol (Oxf)."},{"issue":"7","key":"2021120512262127200_CIT0026","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/0002-9378(76)90504-4","article-title":"Differential ovarian and adrenal vein catheterization","volume":"125","author":"Wentz","year":"1976","journal-title":"Am J Obstet Gynecol."},{"issue":"1","key":"2021120512262127200_CIT0027","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0015-0282(16)47960-4","article-title":"Ovarian and adrenal vein steroids in patients with nonneoplastic hyperandrogenism: selective catheterization findings","volume":"42","author":"Moltz","year":"1984","journal-title":"Fertil Steril."},{"issue":"1","key":"2021120512262127200_CIT0028","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1161\/HYPERTENSIONAHA.119.13866","article-title":"Comprehensive analysis of steroid biomarkers for guiding primary aldosteronism subtyping","volume":"75","author":"Turcu","year":"2020","journal-title":"Hypertension."},{"issue":"2","key":"2021120512262127200_CIT0029","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s12020-019-02007-7","article-title":"The utility of adrenal and ovarian venous sampling in a progesterone-producing adrenal tumor and review of the literature","volume":"66","author":"Duan","year":"2019","journal-title":"Endocrine."},{"issue":"1","key":"2021120512262127200_CIT0030","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1210\/er.2010-0013","article-title":"The molecular biology, biochemistry, and physiology of human steroidogenesis and its disorders","volume":"32","author":"Miller","year":"2011","journal-title":"Endocr Rev."},{"issue":"6","key":"2021120512262127200_CIT0031","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1016\/0002-9378(86)90706-4","article-title":"Treatment of severe androgen excess due to ovarian hyperthecosis with a long-acting gonadotropin-releasing hormone agonist","volume":"154","author":"Steingold","year":"1986","journal-title":"Am J Obstet Gynecol."},{"issue":"2","key":"2021120512262127200_CIT0032","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1007\/BF03350327","article-title":"Postmenopausal virilization in a woman with gonadotropin dependent ovarian hyperthecosis","volume":"21","author":"Manieri","year":"1998","journal-title":"J Endocrinol Invest."},{"issue":"2","key":"2021120512262127200_CIT0033","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1210\/er.2005-0015","article-title":"The science behind 25 years of ovarian stimulation for in vitro fertilization","volume":"27","author":"Macklon","year":"2006","journal-title":"Endocr Rev."},{"issue":"4368","key":"2021120512262127200_CIT0034","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1126\/science.100883","article-title":"Hypophysial responses to continuous and intermittent delivery of hypopthalamic gonadotropin-releasing hormone","volume":"202","author":"Belchetz","year":"1978","journal-title":"Science."},{"issue":"6","key":"2021120512262127200_CIT0035","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1530\/eje.0.1420619","article-title":"Use of a long-acting gonadotrophin-releasing hormone analogue in a postmenopausal woman with hyperandrogenism due to a hilus cell tumour","volume":"142","author":"Pic\u00f3n","year":"2000","journal-title":"Eur J Endocrinol."},{"issue":"5","key":"2021120512262127200_CIT0036","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1210\/jc.2010-1991","article-title":"Gonadotropin-releasing hormone agonist treatment in postmenopausal women with hyperandrogenism of ovarian origin","volume":"96","author":"Vollaard","year":"2011","journal-title":"J Clin Endocrinol Metab."},{"issue":"6","key":"2021120512262127200_CIT0037","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/BF03349077","article-title":"The treatment of a hyperandrogenic and virilizing state in an elderly female with a synthetic LHRH agonist","volume":"11","author":"Parr","year":"1988","journal-title":"J Endocrinol Invest."},{"issue":"2","key":"2021120512262127200_CIT0038","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1046\/j.1365-2265.1997.1050916.x","article-title":"Ovarian hyperthecosis, diabetes and hirsuties in post-menopausal women","volume":"46","author":"Barth","year":"1997","journal-title":"Clin Endocrinol (Oxf)."},{"key":"2021120512262127200_CIT0039","first-page":"18","article-title":"Utilisation of gonadotrophin-releasing hormone (GnRH) analogue to differentiate ovarian from adrenal hyperandrogenism in postmenopausal women","author":"Bahaeldein","year":"2018","journal-title":"Endocrinol Diabetes Metab Case Rep"},{"issue":"7","key":"2021120512262127200_CIT0040","doi-asserted-by":"crossref","first-page":"2796","DOI":"10.1210\/jc.2018-02464","article-title":"Massive ovarian growth in a woman with severe insulin-resistant polycystic ovary syndrome receiving GnRH analogue","volume":"104","author":"Singh","year":"2019","journal-title":"J Clin Endocrinol Metab."},{"issue":"1","key":"2021120512262127200_CIT0041","doi-asserted-by":"crossref","first-page":"G5","DOI":"10.1080\/1464727992000199771","article-title":"The gonadotrophin-releasing hormone antagonist ganirelix\u2013history and introductory data","volume":"5","author":"Out","year":"2002","journal-title":"Hum Fertil (Camb)."},{"issue":"7","key":"2021120512262127200_CIT0042","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1111\/j.1442-2042.2012.02997.x","article-title":"Gonadotropin-releasing hormone: an update review of the antagonists versus agonists","volume":"19","author":"Van Poppel","year":"2012","journal-title":"Int J Urol."},{"issue":"6","key":"2021120512262127200_CIT0043","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1093\/humrep\/17.6.1468","article-title":"An unusual steroid-producing ovarian tumour: case report","volume":"17","author":"Stephens","year":"2002","journal-title":"Hum Reprod."},{"issue":"9","key":"2021120512262127200_CIT0044","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1515\/JPEM.2008.21.9.905","article-title":"Cetrorelix suppression test in the diagnostic work-up of severe hyperandrogenism in adolescence","volume":"21","author":"de Man","year":"2008","journal-title":"J Pediatr Endocrinol Metab."},{"key":"2021120512262127200_CIT0045","first-page":":bcr0120113730","article-title":"Use of cetrorelix in the investigation of testosterone excess in a postmenopausal woman","author":"Chantler","year":"2011","journal-title":"BMJ Case Rep"},{"issue":"8","key":"2021120512262127200_CIT0046","doi-asserted-by":"crossref","first-page":"909","DOI":"10.3109\/01443615.2013.834298","article-title":"Laparoscopic oophorectomy: a novel means of treatment for virilisation","volume":"33","author":"Moore","year":"2013","journal-title":"J Obstet Gynaecol."},{"key":"2021120512262127200_CIT0047","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/13697137.2021.1915273","article-title":"Postmenopausal hyperandrogenism","author":"Yoldemir","year":"2021","journal-title":"Climacteric."},{"key":"2021120512262127200_CIT0048","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/bs.vh.2018.01.003","article-title":"GnRH in the human female reproductive axis","volume":"107","author":"Limonta","year":"2018","journal-title":"Vitam Horm."},{"key":"2021120512262127200_CIT0049","doi-asserted-by":"crossref","first-page":"100876","DOI":"10.1016\/j.yfrne.2020.100876","article-title":"Gonadotropin-releasing hormone analogs: Mechanisms of action and clinical applications in female reproduction","volume":"60","author":"Wu","year":"2021","journal-title":"Front Neuroendocrinol."}],"container-title":["Journal of the Endocrine Society"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jes\/advance-article-pdf\/doi\/10.1210\/jendso\/bvab167\/41108024\/bvab167.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jes\/article-pdf\/5\/12\/bvab167\/41533846\/bvab167.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jes\/article-pdf\/5\/12\/bvab167\/41533846\/bvab167.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,5]],"date-time":"2021-12-05T12:26:53Z","timestamp":1638707213000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jes\/article\/doi\/10.1210\/jendso\/bvab167\/6423475"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,8]]},"references-count":49,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2021,12,1]]}},"URL":"https:\/\/doi.org\/10.1210\/jendso\/bvab167","relation":{},"ISSN":["2472-1972"],"issn-type":[{"value":"2472-1972","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,12,1]]},"published":{"date-parts":[[2021,11,8]]},"article-number":"bvab167"}}